Is There An Opportunity With CLASSYS Inc.'s (KOSDAQ:214150) 38% Undervaluation?

Advertisement

Key Insights

  • CLASSYS' estimated fair value is ₩94,099 based on 2 Stage Free Cash Flow to Equity
  • CLASSYS is estimated to be 38% undervalued based on current share price of ₩58,500
  • The ₩73,500 analyst price target for A214150 is 22% less than our estimate of fair value

Does the July share price for CLASSYS Inc. (KOSDAQ:214150) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting them to their present value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. It may sound complicated, but actually it is quite simple!

We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

Is CLASSYS Fairly Valued?

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:

10-year free cash flow (FCF) estimate

2026202720282029203020312032203320342035
Levered FCF (₩, Millions) ₩173.0b₩218.9b₩253.7b₩284.2b₩310.4b₩333.1b₩353.0b₩370.6b₩386.7b₩401.8b
Growth Rate Estimate SourceAnalyst x8Analyst x6Est @ 15.94%Est @ 12.00%Est @ 9.24%Est @ 7.31%Est @ 5.95%Est @ 5.01%Est @ 4.35%Est @ 3.88%
Present Value (₩, Millions) Discounted @ 7.6% ₩160.8k₩189.1k₩203.8k₩212.1k₩215.4k₩214.8k₩211.6k₩206.5k₩200.3k₩193.4k

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = ₩2.0t

After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.8%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 7.6%.

Terminal Value (TV)= FCF2035 × (1 + g) ÷ (r – g) = ₩402b× (1 + 2.8%) ÷ (7.6%– 2.8%) = ₩8.6t

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= ₩8.6t÷ ( 1 + 7.6%)10= ₩4.2t

The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is ₩6.2t. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of ₩59k, the company appears quite undervalued at a 38% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.

dcf
KOSDAQ:A214150 Discounted Cash Flow July 24th 2025

The Assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at CLASSYS as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.6%, which is based on a levered beta of 0.959. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Check out our latest analysis for CLASSYS

SWOT Analysis for CLASSYS

Strength
  • Earnings growth over the past year exceeded the industry.
  • Debt is not viewed as a risk.
Weakness
  • Dividend is low compared to the top 25% of dividend payers in the Medical Equipment market.
Opportunity
  • Annual earnings are forecast to grow faster than the South Korean market.
  • Trading below our estimate of fair value by more than 20%.
Threat
  • No apparent threats visible for A214150.

Next Steps:

Whilst important, the DCF calculation ideally won't be the sole piece of analysis you scrutinize for a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. Why is the intrinsic value higher than the current share price? For CLASSYS, there are three important elements you should further examine:

  1. Financial Health: Does A214150 have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
  2. Future Earnings: How does A214150's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the KOSDAQ every day. If you want to find the calculation for other stocks just search here.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KOSDAQ:A214150

CLASSYS

Provides medical aesthetics devices worldwide.

Outstanding track record and undervalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7061.6% undervalued
6 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17036.6% undervalued
27 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38026.3% undervalued
19 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7448.8% undervalued
45 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative

Updated Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28023.3% undervalued
89 users have followed this narrative
9 users have commented on this narrative
0 users have liked this narrative
OS
oscargarcia
AVGO logo
oscargarcia on Broadcom ·

A tech powerhouse quietly powering the world’s AI infrastructure.

Fair Value:US$65026.3% undervalued
44 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
DE
DeathSmiIes
HOVR logo
DeathSmiIes on New Horizon Aircraft ·

HORIZON AIRCRAFT (HOVR) Institutional Investor Package

Fair Value:US$2088.0% undervalued
12 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.7% undervalued
124 users have followed this narrative
2 users have commented on this narrative
36 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9722.1% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1930.3% undervalued
46 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative